• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Viramune XR (nevirapine) extended-release tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

January 2014

Summary View

6 ADVERSE REACTIONS

6.1 Clinical Trial Experience in Adult Patients
  • added ..... Table 2: drug reaction with eosinophilia and systemic symptoms (DRESS)